<p>独立认可强调了 Cognizin® 在科学支持的认知表现领域的领导地位</p>
<p>, /PRNewswire/ -- Kyowa Hakko USA 今天宣布，Cognizin®（胞苷酸），由 Kyowa Hakko Bio Co. 生产的胞苷酸品牌形式，已被全球市场情报公司 Mintel 和消费者分析领导者 Black Swan Data 认定为 “2026 年值得关注的功能性成分”。这一第三方验证突显了 Cognizin® 在快速增长的脑健康和心理表现市场中的核心地位。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Cognizin 标志</p>
<p>根据 Mintel/Black Swan 的分析，65% 的全球产品发布包含 Cognizin®，并声称具有脑部或神经系统的益处，表明对基于证据的认知支持的强劲和加速需求。Cognizin® 现在以多种形式出现，从软糖和棒棒糖到能量饮料和高级补充剂，使其成为当今功能性营养领域中最具多样性和令人兴奋的成分之一。</p>
<p>&#34;被评为 2026 年值得关注的成分不仅仅是一个美好的标题；它确认了配方师和消费者已经告诉我们的事实，&#34; Kyowa Hakko USA 科学事务高级经理 Katie Emerson, MS, RD 说。&#34;Cognizin® 不仅仅是货架上拥挤的另一种智能药物。它是一种经过临床研究、严格制造的成分，品牌围绕其构建了整个产品故事。这一认可验证了多年来对科学和质量的投资，并标志着 Cognizin® 主流突破的开始。&#34;</p>
<p><strong>认可背后的数据</strong> Mintel/Black Swan 的研究突显了塑造 Cognizin® 发展轨迹的几个关键趋势：</p>
<ul>
<li>强烈的脑健康关注：65% 的全球 Cognizin® 发布声称具有脑部或神经系统的益处，使认知支持成为该成分的主导定位。</li>
<li>不断增长的地理足迹：目前大多数发布集中在北美（49%）和欧洲（34%），表明在其他地区有强劲的采用和巨大的增长机会。</li>
<li>多样化的产品形式：Cognizin® 主要出现在营养饮料（36%）、能量饮料（32%）和补充剂（23%）中，以及功能性糖果和内在美容等新兴形式。</li>
</ul>
<p>最近发布的包含 Cognizin® 的产品包括科学支持的产品，如 Qunol、BUM Energy、MOSH 和 Magic Mind，展示了品牌如何利用 Cognizin® 在日常环境中提供益处。</p>
<p>&#34;看到 Cognizin® 在多种形式中出现强调了它的多样性和影响力，&#34; Emerson 补充道。&#34;这告诉我们，认知支持不再是小众，而是成为了基本期望。&#34;</p>
<p><strong>为什么 Cognizin® 在拥挤的智能药物市场中脱颖而出</strong> Cognizin® 是胞苷酸的品牌形式，一种支持磷脂酰胆碱生产的营养素，磷脂酰胆碱是脑细胞膜的关键成分，也是脑细胞能量的重要参与者。与许多普通的智能药物不同，Cognizin® 拥有丰富的研究支持。</p>
<p><strong>关键差异化因素包括：</strong></p>
<ul>
<li>临床证据：研究表明，胞苷酸可以支持注意力、记忆和认知表现，包括基于 MRI 的研究显示脑活动的变化。</li>
<li>脑能量支持研究表明，胞苷酸可以将脑 ATP（细胞能量）增加约 13%，直接支持心理能量和专注力。</li>
<li>非刺激性特征：Cognizin® 提供认知益处，而不依赖于咖啡因或强刺激物，使其成为消费者的一个有吸引力的选择。</li>
<li>质量和一致性：由 Kyowa Hakko 使用专有发酵技术和严格的质量控制生产，Cognizin® 为品牌和消费者提供一致的纯度和可追溯性。</li>
</ul>
<p>&#34;在一个消费者越来越怀疑模糊的 ‘脑部提升’ 声明的时代，Cognizin® 的科学优先故事显得尤为重要，&#34; Emerson 说。&#34;品牌希望拥有能够经得起高度知情的购物者评估的成分，而 Cognizin 正是如此。&#34;</p>
<p>这一认可也恰逢心理表现和倦怠成为头条话题之际。最近的职场和健康研究表明，员工和消费者在专注、注意力和心理疲劳方面面临挑战。</p>
<p>&#34;2026 年将成为人们停止接受平庸过程和杂乱思维作为新常态的一年，&#34; Emerson 说。&#34;他们正在寻找能够帮助他们在工作、健身房和家中保持敏锐的实用工具。Cognizin® 为配方师提供了一种科学基础的方法来构建这些解决方案。&#34;</p>
<p><strong>支持全球创新品牌</strong> “2026 年值得关注的功能性成分” 这一称号已经激励了饮料、补充剂和功能性食品领域的新合作和产品概念。Kyowa Hakko USA 正在通过以下方式扩大对合作伙伴的支持：</p>
<ul>
<li>针对饮料、粉末、软糖和新型形式的配方指导</li>
<li>将复杂研究转化为清晰消费者语言的基于科学的营销资产</li>
<li>突出使用 Cognizin® 配方的品牌的联合营销机会</li>
<li>针对医疗专业人士、零售商和配方师的教育计划</li>
</ul>
<p>&#34;我们现在看到的一些最令人兴奋的创新来自于那些理解认知表现是新能量的品牌，&#34; Emerson 说。&#34;这些品牌选择 Cognizin®，因为他们希望他们的产品能够适应未来，并与市场的发展方向保持一致，而不是停留在过去。&#34;</p>
<p><strong>— Cognizin</strong> ® <strong>—</strong></p>
<p><strong>关于京和发酵美国</strong> 京和发酵美国是京和发酵生物有限公司的子公司，这是一家拥有超过 75 年发酵、纯化和改性生物活性物质专业知识的全球生物技术公司。京和发酵生物致力于通过科学与自然创造创新解决方案，以改善全球人们的健康和福祉。凭借尖端的研究能力，京和发酵生物致力于开发有科学证据支持的独特成分。欲了解更多信息，请访问 kyowa-usa.com。</p>
<p><strong>关于 Cognizin®</strong> Cognizin® 乙酰胆碱是由京和发酵生物有限公司生产的一种经过临床研究的品牌形式的乙酰胆碱，这是一种在体内天然合成的物质，对大脑健康尤为重要。乙酰胆碱是一种强效的大脑健康营养素。Cognizin® 是一种专有形式的乙酰胆碱，经过临床研究支持其对心理能量、专注力和注意力的支持。Cognizin® 通过发酵过程制造，确保高质量和高纯度。Cognizin® 还具有高度稳定性，符合 GRAS 标准，超纯且无过敏原。Cognizin® 可以作为膳食成分在美国销售，用于补充剂、食品和饮料，并在欧盟被批准作为食品补充剂的新型食品成分。欲了解更多关于 Cognizin® 的信息，请访问 Cognizin.com。</p>
<p>来源：京和发酵美国</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3"/></p>

<p>Kyowa Hakko USA 宣布，Cognizin®（胞苷酸）被 Mintel 和 Black Swan Data 评选为 “2026 年值得关注的功能性成分”。这一认可突显了 Cognizin® 在日益增长的脑健康市场中的重要作用，全球 65% 的产品发布都将其作为认知支持成分。该成分用途广泛，出现在各种形式中，如软糖和能量饮料，并且有临床研究支持其对注意力和记忆的益处。该称号预计将激励认知表现领域的新产品创新</p>

<p><em>Independent recognition underscores Cognizin®'s role as a</em> <em>science‑backed leader in cognitive performance</em></p>
<div class="lb-trans"><p>独立认可强调了 Cognizin® 在科学支持的认知表现领域的领导地位</p>
</div><p>, /PRNewswire/ -- Kyowa Hakko USA today announced that Cognizin® (citicoline), the branded form of citicoline manufactured by Kyowa Hakko Bio Co., has been recognized as a leading &#34;Functional Ingredient to Watch in 2026&#34; by global market intelligence firm Mintel and consumer analytics leader Black Swan Data. This third‑party validation highlights Cognizin®'s position at the center of the rapidly growing brain health and mental performance market.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Kyowa Hakko USA 今天宣布，Cognizin®（胞苷酸），由 Kyowa Hakko Bio Co. 生产的胞苷酸品牌形式，已被全球市场情报公司 Mintel 和消费者分析领导者 Black Swan Data 认定为 “2026 年值得关注的功能性成分”。这一第三方验证突显了 Cognizin® 在快速增长的脑健康和心理表现市场中的核心地位。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Cognizin Logo</p>
<div class="lb-trans"><p>Cognizin 标志</p>
</div><p>According to the Mintel/Black Swan analysis, 65% of global product launches featuring Cognizin® include a brain or nervous system benefit, signaling strong and accelerating demand for evidence‑based cognitive support. Cognizin® now appears across a wide range of formats, from gummies and lollipops to energy drinks and advanced supplements, making it one of the most versatile and exciting ingredients in the field of functional nutrition today.</p>
<div class="lb-trans"><p>根据 Mintel/Black Swan 的分析，65% 的全球产品发布包含 Cognizin®，并声称具有脑部或神经系统的益处，表明对基于证据的认知支持的强劲和加速需求。Cognizin® 现在以多种形式出现，从软糖和棒棒糖到能量饮料和高级补充剂，使其成为当今功能性营养领域中最具多样性和令人兴奋的成分之一。</p>
</div><p>&#34;Being named an ingredient to watch in 2026 is more than a nice headline; it confirms what formulators and consumers are already telling us,&#34; said Katie Emerson, MS, RD, Senior Manager, Scientific Affairs at Kyowa Hakko USA. &#34;Cognizin® isn't just another nootropic on a crowded shelf. It is a clinically researched, rigorously manufactured ingredient that brands are building entire product stories around. This recognition validates years of investment in science and quality and marks the beginning of Cognizin®'s mainstream breakout.&#34;</p>
<div class="lb-trans"><p>&#34;被评为 2026 年值得关注的成分不仅仅是一个美好的标题；它确认了配方师和消费者已经告诉我们的事实，&#34; Kyowa Hakko USA 科学事务高级经理 Katie Emerson, MS, RD 说。&#34;Cognizin® 不仅仅是货架上拥挤的另一种智能药物。它是一种经过临床研究、严格制造的成分，品牌围绕其构建了整个产品故事。这一认可验证了多年来对科学和质量的投资，并标志着 Cognizin® 主流突破的开始。&#34;</p>
</div><p><strong>Data behind the recognition</strong> The Mintel/Black Swan work highlights several key trends shaping Cognizin®'s trajectory:</p>
<div class="lb-trans"><p><strong>认可背后的数据</strong> Mintel/Black Swan 的研究突显了塑造 Cognizin® 发展轨迹的几个关键趋势：</p>
</div><ul>
<li>Strong brain‑health focus: 65% of global Cognizin® launches carry a brain or nervous system claim, making cognitive support the dominant positioning for the ingredient.</li>
<li>Growing geographic footprint: Most launches are currently concentrated in North America (49%) and Europe (34%), indicating both strong adoption and substantial opportunities for growth in other regions.</li>
<li>Diverse product formats: Cognizin® primarily appears in nutrition drinks (36%), energy drinks (32%), and supplements (23%), as well as emerging formats such as functional confections and beauty-from-within products.</li>
</ul>
<div class="lb-trans"><ul>
<li>强烈的脑健康关注：65% 的全球 Cognizin® 发布声称具有脑部或神经系统的益处，使认知支持成为该成分的主导定位。</li>
<li>不断增长的地理足迹：目前大多数发布集中在北美（49%）和欧洲（34%），表明在其他地区有强劲的采用和巨大的增长机会。</li>
<li>多样化的产品形式：Cognizin® 主要出现在营养饮料（36%）、能量饮料（32%）和补充剂（23%）中，以及功能性糖果和内在美容等新兴形式。</li>
</ul>
</div><p>Recent launches featuring Cognizin® include science-backed products, such as Qunol, BUM Energy, MOSH, and Magic Mind, which showcase how brands use Cognizin® to deliver benefits in everyday settings.</p>
<div class="lb-trans"><p>最近发布的包含 Cognizin® 的产品包括科学支持的产品，如 Qunol、BUM Energy、MOSH 和 Magic Mind，展示了品牌如何利用 Cognizin® 在日常环境中提供益处。</p>
</div><p>&#34;Seeing Cognizin® across a wide range of formats underscores its versatility and impact,&#34; Emerson added. &#34;It tells us cognitive support is no longer niche but has become a baseline expectation.&#34;</p>
<div class="lb-trans"><p>&#34;看到 Cognizin® 在多种形式中出现强调了它的多样性和影响力，&#34; Emerson 补充道。&#34;这告诉我们，认知支持不再是小众，而是成为了基本期望。&#34;</p>
</div><p><strong>Why Cognizin® stands out in a crowded nootropics landscape</strong> Cognizin® is a branded form of citicoline, a nutrient that supports the production of phosphatidylcholine, a key component of brain cell membranes and a critical player in brain cell energy. Unlike many generic nootropics, Cognizin® is backed by a substantial research portfolio.</p>
<div class="lb-trans"><p><strong>为什么 Cognizin® 在拥挤的智能药物市场中脱颖而出</strong> Cognizin® 是胞苷酸的品牌形式，一种支持磷脂酰胆碱生产的营养素，磷脂酰胆碱是脑细胞膜的关键成分，也是脑细胞能量的重要参与者。与许多普通的智能药物不同，Cognizin® 拥有丰富的研究支持。</p>
</div><p><strong>Key differentiators include:</strong></p>
<div class="lb-trans"><p><strong>关键差异化因素包括：</strong></p>
</div><ul>
<li>Clinical evidence: Studies have demonstrated that citicoline can support attention, memory, and cognitive performance, including MRI-based research that shows changes in brain activity.</li>
<li>Brain energy support studies indicate citicoline can increase brain ATP (cellular energy) by approximately 13%, directly supporting mental energy and focus.</li>
<li>Non-stimulant profile: Cognizin® delivers cognitive benefits without relying on caffeine or harsh stimulants, making it an attractive option for consumers.</li>
<li>Quality and consistency: Produced by Kyowa Hakko using proprietary fermentation technology and strict quality controls, Cognizin® offers consistent purity and traceability for brands and consumers.</li>
</ul>
<div class="lb-trans"><ul>
<li>临床证据：研究表明，胞苷酸可以支持注意力、记忆和认知表现，包括基于 MRI 的研究显示脑活动的变化。</li>
<li>脑能量支持研究表明，胞苷酸可以将脑 ATP（细胞能量）增加约 13%，直接支持心理能量和专注力。</li>
<li>非刺激性特征：Cognizin® 提供认知益处，而不依赖于咖啡因或强刺激物，使其成为消费者的一个有吸引力的选择。</li>
<li>质量和一致性：由 Kyowa Hakko 使用专有发酵技术和严格的质量控制生产，Cognizin® 为品牌和消费者提供一致的纯度和可追溯性。</li>
</ul>
</div><p>&#34;In an era where consumers are increasingly skeptical of vague 'brain boosting' claims, Cognizin®'s science‑first story matters,&#34; Emerson said. &#34;Brands want ingredients that can stand up to evaluation from highly informed shoppers, and Cognizin does exactly that.&#34;</p>
<div class="lb-trans"><p>&#34;在一个消费者越来越怀疑模糊的 ‘脑部提升’ 声明的时代，Cognizin® 的科学优先故事显得尤为重要，&#34; Emerson 说。&#34;品牌希望拥有能够经得起高度知情的购物者评估的成分，而 Cognizin 正是如此。&#34;</p>
</div><p>The recognition also comes at a moment when mental performance and burnout are front‑page topics. Recent workplace and health research shows that employees and consumers are struggling with focus, attention, and mental fatigue.</p>
<div class="lb-trans"><p>这一认可也恰逢心理表现和倦怠成为头条话题之际。最近的职场和健康研究表明，员工和消费者在专注、注意力和心理疲劳方面面临挑战。</p>
</div><p>&#34;2026 is shaping up to be the year people stop accepting mediocre process and scattered thoughts as the new normal,&#34; Emerson said. &#34;They are looking for practical, daily tools that help them show up sharp—at work, in the gym, and at home. Cognizin® gives formulators a scientifically grounded way to build those solutions.&#34;</p>
<div class="lb-trans"><p>&#34;2026 年将成为人们停止接受平庸过程和杂乱思维作为新常态的一年，&#34; Emerson 说。&#34;他们正在寻找能够帮助他们在工作、健身房和家中保持敏锐的实用工具。Cognizin® 为配方师提供了一种科学基础的方法来构建这些解决方案。&#34;</p>
</div><p><strong>Supporting innovator brands worldwide</strong> The &#34;Functional Ingredient to Watch in 2026&#34; designation is already inspiring new collaborations and product concepts across beverages, supplements, and functional foods. Kyowa Hakko USA is expanding its support for partners through:</p>
<div class="lb-trans"><p><strong>支持全球创新品牌</strong> “2026 年值得关注的功能性成分” 这一称号已经激励了饮料、补充剂和功能性食品领域的新合作和产品概念。Kyowa Hakko USA 正在通过以下方式扩大对合作伙伴的支持：</p>
</div><ul>
<li>Formulation guidance for beverages, powders, gummies, and novel formats</li>
<li>Science‑based marketing assets translating complex research into clear consumer language</li>
<li>Co‑marketing opportunities spotlighting brands that formulate with Cognizin®</li>
<li>Education initiatives for healthcare professionals, retailers, and formulators</li>
</ul>
<div class="lb-trans"><ul>
<li>针对饮料、粉末、软糖和新型形式的配方指导</li>
<li>将复杂研究转化为清晰消费者语言的基于科学的营销资产</li>
<li>突出使用 Cognizin® 配方的品牌的联合营销机会</li>
<li>针对医疗专业人士、零售商和配方师的教育计划</li>
</ul>
</div><p>&#34;Some of the most exciting innovations we're seeing right now are coming from brands that understand that cognitive performance is the new energy,&#34; Emerson said. &#34;Those brands are choosing Cognizin® because they want their products to be future‑proof and aligned with where the market is going, not where it's been.&#34;</p>
<div class="lb-trans"><p>&#34;我们现在看到的一些最令人兴奋的创新来自于那些理解认知表现是新能量的品牌，&#34; Emerson 说。&#34;这些品牌选择 Cognizin®，因为他们希望他们的产品能够适应未来，并与市场的发展方向保持一致，而不是停留在过去。&#34;</p>
</div><p><strong>— Cognizin</strong> ® <strong>—</strong></p>
<div class="lb-trans"><p><strong>— Cognizin</strong> ® <strong>—</strong></p>
</div><p><strong>About Kyowa Hakko USA</strong> Kyowa Hakko USA is a subsidiary of Kyowa Hakko Bio Co., Ltd., a global biotechnology company with over 75 years of expertise in fermentation, purification, and modification of bioactive substances. Kyowa Hakko Bio is dedicated to improving the health and well-being of people worldwide by creating innovative solutions with science and nature. With cutting-edge research capabilities, Kyowa Hakko Bio is committed to developing unique ingredients supported by scientific evidence. For more information, visit kyowa-usa.com.</p>
<div class="lb-trans"><p><strong>关于京和发酵美国</strong> 京和发酵美国是京和发酵生物有限公司的子公司，这是一家拥有超过 75 年发酵、纯化和改性生物活性物质专业知识的全球生物技术公司。京和发酵生物致力于通过科学与自然创造创新解决方案，以改善全球人们的健康和福祉。凭借尖端的研究能力，京和发酵生物致力于开发有科学证据支持的独特成分。欲了解更多信息，请访问 kyowa-usa.com。</p>
</div><p><strong>About Cognizin®</strong> Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, and attention. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. Cognizin® can be sold as a dietary ingredient for supplements, foods, and beverages in the United States and is approved as a novel food ingredient in the EU for food supplements. For more information on Cognizin®, visit Cognizin.com.</p>
<div class="lb-trans"><p><strong>关于 Cognizin®</strong> Cognizin® 乙酰胆碱是由京和发酵生物有限公司生产的一种经过临床研究的品牌形式的乙酰胆碱，这是一种在体内天然合成的物质，对大脑健康尤为重要。乙酰胆碱是一种强效的大脑健康营养素。Cognizin® 是一种专有形式的乙酰胆碱，经过临床研究支持其对心理能量、专注力和注意力的支持。Cognizin® 通过发酵过程制造，确保高质量和高纯度。Cognizin® 还具有高度稳定性，符合 GRAS 标准，超纯且无过敏原。Cognizin® 可以作为膳食成分在美国销售，用于补充剂、食品和饮料，并在欧盟被批准作为食品补充剂的新型食品成分。欲了解更多关于 Cognizin® 的信息，请访问 Cognizin.com。</p>
</div><p>SOURCE Kyowa Hakko U.S.A</p>
<div class="lb-trans"><p>来源：京和发酵美国</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIyJk5ld3NJdGVtSWQ9Tlk2ODI3NyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjIwOTExUFJfTkVXU19VU1BSX19fX19OWTY4Mjc3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY68277&amp;Transmission_Id=202601220911PR_NEWS_USPR_____NY68277&amp;DateId=20260122"/></p>

09:11 ET
			
			
				COGNIZIN® CITICOLINE NAMED "FUNCTIONAL INGREDIENT TO WATCH IN 2026" BY MINTEL & BLACK SWAN DATA, SHOWCASING ITS EXPLOSIVE GROWTH IN THE BRAIN HEALTH CATEGORY

COGNIZIN® CITICOLINE 被 Mintel 和 Black Swan Data 评选为 “2026 年值得关注的功能性成分”，展示了其在脑健康领域的迅猛增长